IMTXW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW
Should you be buying Immatics stock or one of its competitors? The main competitors of Immatics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.
180 Life Sciences (NASDAQ:ATNFW) and Immatics (NASDAQ:IMTXW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations, media sentiment and community ranking.
180 Life Sciences and Immatics both received 0 outperform votes by MarketBeat users.
In the previous week, Immatics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Immatics and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.49 beat Immatics' score of 0.00 indicating that Immatics is being referred to more favorably in the news media.
Summary
Immatics beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks.
Get Immatics News Delivered to You Automatically
Sign up to receive the latest news and ratings for IMTXW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IMTXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
IMTXW vs. The Competition
Immatics Competitors List
Related Companies and Tools